Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS Data

Clinical trial NCT06392763 · COMPLETED

Trial details

NCT number: NCT06392763
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Diffuse Large B-cell Lymphoma Acute Lymphoblastic Leukemia (ALL)

Start date: 2021-08-03
Primary completion: 2023-04-28
Enrollment: 602

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.